logo

For the Inventor, By the Inventor

Elmwood Park, NJ, United States of America

Barbara E Kurys

This inventor holds 17 USPTO granted patents, plus 2 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoechst Roussel Pharmaceuticals, Hoechst Marion Roussel. Active years: 1990-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barbara E Kurys. Retrieved from https://idiyas.com/inventor/barbara-e-kurys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 83(Granted Patents)


Location History:

  • Morris Plains, NJ (US) (1990)
  • Elmwood Park, NJ (US) (1990 - 1998)
  • Loveland, OH (US) (1997 - 1999)
  • Long Valley, NJ (US) (1999)

Company Filing History:

goldMedal11 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
silverMedal6 out of 236 
 
Hoechst Marion Roussel
 patents

Years Active: 1990-1999

Loading Chart...
Loading Chart...
Areas of Expertise:
Pyridinylamino Isoindolines
Benzo(b)pyrrolobenzodiazepines
Heteroaryl-8-azabicyclo
Physostigmine Derivatives
Analgesic Compounds
Memory Enhancers
Antipsychotic Agents
Carbonate Derivatives
17 patents (USPTO):Explore Patents
1. 6004977 - N-(pyridinylamino) isoindolines and related compounds (1999-12-21),
2. 5948798 - Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles (1999-09-07),
3. 5728717 - Pyridiniminyl-1,2-benzisothiazoles (1998-03-17),
4. 5726323 - 4- and 6-carbamates related to physostigmine and intermediates for the (1998-03-10),
5. 5668154 - Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles (1997-09-16),
6. 5591864 - 4-and 6-carbamates related to physostigmine and intermediates for the (1997-01-07),
7. 5340936 - 8-azabicyclo[3.2.1]octane methanone and corresponding oximes (1994-08-23),
8. 5334599 - Heteroaryl-8-azabicyclo[3,2,1]octanes as antipsychotic agents, (1994-08-02),
9. 5260452 - 4- and 6-carbamates related to physostigmine and intermediates for the (1993-11-09),
10. 5234931 - Heteroaryl-8-azabicyclo[3.2.1]octanes as antipsychotic agents, (1993-08-10),
11. 5189161 - Benzo(b)pyrrolobenzodiazepines (1993-02-23),
12. 5187165 - Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and (1993-02-16),
13. 5081117 - 4- and 6-carbamates related to physostigmine and intermediates for the (1992-01-14),
14. 5015738 - Benzo(b)pyrrolobenzodiazepines (1991-05-14),
15. 4983601 - Benzo(b)pyrrolobenzodiazepines (1991-01-08),

Title: The Innovative Contributions of Barbara E. Kurys

Introduction

Barbara E. Kurys is a notable inventor based in Elmwood Park, NJ (US), recognized for her significant contributions to the field of pharmaceuticals. With a total of 17 patents to her name, she has made remarkable advancements in the development of compounds aimed at treating memory dysfunction and depression.

Latest Patents

Among her latest patents are the N-(pyridinylamino) isoindolines and related compounds. This patent discloses novel N-(pyridinylamino) isoindolines, intermediates, and processes for their preparation. It also outlines methods for relieving memory dysfunction and treating depression using these compounds. Another significant patent involves pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles. This patent details novel compounds, intermediates, and processes for their preparation, along with methods for addressing memory dysfunction and depression.

Career Highlights

Barbara has worked with prominent companies such as Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel. Her work in these organizations has contributed to her extensive knowledge and expertise in pharmaceutical innovations.

Collaborations

Throughout her career, Barbara has collaborated with esteemed colleagues, including Edward J. Glamkowski and David M. Fink. These partnerships have further enriched her research and development efforts.

Conclusion

Barbara E. Kurys stands out as a pioneering inventor whose work has the potential to impact the treatment of memory dysfunction and depression significantly. Her innovative spirit and dedication to research continue to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…